This inventor holds 4 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Asana Biosciences, LLC. Active years: 2016-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Hyderabad, IN (US) (2016)
- Hyderabad, IN (2017 - 2021)
Company Filing History:
Years Active: 2016-2021
Title: Innovations in Oncology: The Patents of Vijay Kumar Nyavanandi
Introduction
Vijay Kumar Nyavanandi, based in Hyderabad, Telangana, India, is an innovative inventor who has made significant contributions to the field of oncology through his patent work. With a total of four patents, Nyavanandi focuses on developing novel compounds to combat diseases characterized by abnormal cellular proliferation, particularly cancer.
Latest Patents
Nyavanandi's latest patents include groundbreaking research on "Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways." The applications provide new quinazolines and azaquinazolines, along with pharmaceutically acceptable salts. These compounds aim to co-regulate important signaling pathways involved in cancer progression by administering a therapeutically effective amount to patients. The potential applications extend to various diseases arising from the dysregulation of these pathways, notably cancer.
Career Highlights
Vijay Kumar Nyavanandi works for Asana Biosciences, LLC, where he applies his expertise in drug development and patent innovation. His work is pivotal in advancing therapeutic options for patients suffering from malignancies. With a strong focus on the pharmaceutical industry, Nyavanandi's inventions enhance the understanding of cancer treatment methodologies.
Collaborations
Throughout his career, Nyavanandi has collaborated with notable colleagues, including Scott Kevin Thompson and Roger Astbury Smith. These partnerships facilitate a multidisciplinary approach to research and development, bolstering the effectiveness of their innovative contributions in medical science.
Conclusion
Vijay Kumar Nyavanandi exemplifies the vital role of inventors in therapeutic innovation, particularly in the realm of oncology. His patents reflect a commitment to enhancing treatment modalities for cancer and other diseases driven by cellular dysregulation. As his research continues to evolve, it holds promise for significant advances in medical treatments and improved patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile